Literature DB >> 12810425

Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis.

T J M Smeets1, E C Barg, M C Kraan, M D Smith, F C Breedveld, P P Tak.   

Abstract

BACKGROUND: Synovial tissue (ST) from end stage destructive rheumatoid arthritis (RA) and arthroscopic biopsies obtained during active inflammation might exhibit different characteristics.
OBJECTIVE: To define the cell infiltrate and the expression of proinflammatory cytokines, angiogenic factors, and matrix metalloproteinases (MMPs) in ST selected at arthroscopy compared with that from end stage RA.
METHODS: Synovial biopsy specimens were obtained from the actively inflamed knee joints of 13 patients with chronic RA by arthroscopy and compared with ST from 10 patients with end stage, destructive RA. Immunohistological analysis was performed to detect T cells, plasma cells, macrophages, fibroblast-like synoviocytes (FLS), and the expression of interleukin (IL)1beta, IL6, tumour necrosis factor alpha (TNFalpha), MMP-1, MMP-3, MMP-13, TIMP-1, and VEGF.
RESULTS: The expression of CD68+ macrophages was significantly higher in ST selected at arthroscopy than in samples obtained at surgery, both in the intimal lining layer and in the synovial sublining. The expression of CD3+ T cells also tended to be higher in arthroscopic samples. The expression of TNFalpha, IL6, MMP-1, MMP-3, MMP-13, TIMP-1, and VEGF was on average higher in ST obtained at arthroscopy. In contrast, the expression of IL1beta was on average higher in surgical samples.
CONCLUSION: Active arthritis activity is associated with increased cell infiltration, expression of proinflammatory cytokines, MMPs, and angiogenic growth factors in synovial biopsy samples selected at arthroscopy. Increased expression of IL1beta in the synovium of patients with destructive RA requiring joint replacement may well reflect the important role of IL1beta in cartilage and bone destruction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810425      PMCID: PMC1754593          DOI: 10.1136/ard.62.7.635

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  25 in total

1.  Intraarticular variability of synovial membrane histology, immunohistology, and cytokine mRNA expression in patients with rheumatoid arthritis.

Authors:  B Kirkham; I Portek; C S Lee; B Stavros; A Lenarczyk; M Lassere; J Edmonds
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

2.  Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity.

Authors:  P P Tak; T J Smeets; M R Daha; P M Kluin; K A Meijers; R Brand; A E Meinders; F C Breedveld
Journal:  Arthritis Rheum       Date:  1997-02

3.  Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium.

Authors:  G S Firestein; K Nguyen; K R Aupperle; M Yeo; D L Boyle; N J Zvaifler
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

Review 4.  Observations on the microenvironmental nature of cartilage degradation in rheumatoid arthritis.

Authors:  D E Woolley; L C Tetlow
Journal:  Ann Rheum Dis       Date:  1997-03       Impact factor: 19.103

5.  Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ.

Authors:  D Mulherin; O Fitzgerald; B Bresnihan
Journal:  Br J Rheumatol       Date:  1996-12

6.  p53 overexpression in synovial tissue from patients with early and longstanding rheumatoid arthritis compared with patients with reactive arthritis and osteoarthritis.

Authors:  P P Tak; T J Smeets; D L Boyle; M C Kraan; Y Shi; S Zhuang; N J Zvaifler; F C Breedveld; G S Firestein
Journal:  Arthritis Rheum       Date:  1999-05

7.  Asymptomatic synovitis precedes clinically manifest arthritis.

Authors:  M C Kraan; H Versendaal; M Jonker; B Bresnihan; W J Post; B A t Hart; F C Breedveld; P P Tak
Journal:  Arthritis Rheum       Date:  1998-08

Review 8.  Joint inflammation and cartilage destruction may occur uncoupled.

Authors:  W B van den Berg
Journal:  Springer Semin Immunopathol       Date:  1998

9.  Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis.

Authors:  P P Tak; P A van der Lubbe; A Cauli; M R Daha; T J Smeets; P M Kluin; A E Meinders; G Yanni; G S Panayi; F C Breedveld
Journal:  Arthritis Rheum       Date:  1995-10

10.  Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion.

Authors:  L C Tetlow; D E Woolley
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

View more
  50 in total

1.  Increased BMP expression in arthrofibrosis after TKA.

Authors:  Tilman Pfitzner; Sven Geissler; Georg Duda; Carsten Perka; Georg Matziolis
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-17       Impact factor: 4.342

2.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

3.  Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis.

Authors:  J J Haringman; D M Gerlag; A H Zwinderman; T J M Smeets; M C Kraan; D Baeten; I B McInnes; B Bresnihan; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-12-02       Impact factor: 19.103

4.  Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?

Authors:  Salih Pay; Hakan Erdem; Aysel Pekel; Ismail Simsek; Ugur Musabak; Ali Sengul; Ayhan Dinc
Journal:  Rheumatol Int       Date:  2005-10-05       Impact factor: 2.631

Review 5.  Pathogenesis of spondyloarthritis: insights from synovial membrane studies.

Authors:  Leen De Rycke; Elli Kruithof; Bernard Vandooren; Paul P Tak; Dominique Baeten
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

6.  Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment.

Authors:  A W R van Kuijk; P Reinders-Blankert; T J M Smeets; B A C Dijkmans; P P Tak
Journal:  Ann Rheum Dis       Date:  2006-05-25       Impact factor: 19.103

7.  Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis.

Authors:  D Baeten; J Houbiers; E Kruithof; B Vandooren; F Van den Bosch; A M Boots; E M Veys; A M M Miltenburg; F De Keyser
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

8.  Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis.

Authors:  Yong Wook Park; Young Mo Kang; Joe Butterfield; Michael Detmar; Jörg J Goronzy; Cornelia M Weyand
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

9.  Physiologic deformational loading does not counteract the catabolic effects of interleukin-1 in long-term culture of chondrocyte-seeded agarose constructs.

Authors:  Eric G Lima; Andrea R Tan; Timon Tai; Liming Bian; Gerard A Ateshian; James L Cook; Clark T Hung
Journal:  J Biomech       Date:  2008-09-26       Impact factor: 2.712

10.  Evaluation of arthroscopy and macroscopic scoring.

Authors:  Erik af Klint; Anca I Catrina; Peter Matt; Petra Neregråd; Jon Lampa; Ann-Kristin Ulfgren; Lars Klareskog; Staffan Lindblad
Journal:  Arthritis Res Ther       Date:  2009-06-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.